EX-10.1
from 8-K
74 pages
Underwriting Agreement Athenex, Inc. 35,333,334 Shares of Common Stock Pre-Funded Warrants to Purchase 4,666,666 Shares of Common Stock Common Warrants to Purchase 40,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-10.4
from 10-Q
48 pages
Equity Purchase Agreement Among Tihe Capital (Beijing) Co. Ltd.（泰和中投投资基金管理（北京）有限公司）, Athenex Api Limited, Athenex Pharmaceuticals (China) Limited, Polymed Therapeutics, Inc. and Athenex, Inc. Dated July 7, 2022
12/34/56
EX-10.1
from 8-K
10 pages
This Consulting Agreement (The “Agreement”) Is Made and Entered Into This 1st Day of January 2022 by and Between Athenex, Inc., a Delaware Corporation With Its Principal Office at Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203 (“Athenex”) and Simon Pedder, With Its Principal Office at #### (“Consultant”). Athenex and Consultant Are Sometime Referred to Herein Each as a “Party,” and Together as the “Parties.” 1. Services
12/34/56
EX-10.1
from 8-K
12 pages
This Consulting Agreement (The “Agreement”) Is Made and Entered Into This 1st Day of September 2021 by and Between Athenex, Inc., a Delaware Corporation With Its Principal Office at Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203 (“Athenex”) and Randoll Sze (“Consultant”). Athenex and Consultant Are Sometimes Referred to Herein Each as a “Party,” and Together as the “Parties.” 1. Services 1.1. Services
12/34/56
